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Research
Aflatoxins, toxic metabolites of Aspergillus
ﬂavus and Aspergillus parasiticus fungi, are nat-
urally occurring contaminants of food.
Although aflatoxins have been a problem
throughout history, they have been recognized
as signiﬁcant contaminants within agriculture
only since the 1960s. The establishment of
regulatory limits on traded foods, the enforce-
ment of these limits through food monitoring,
and the implementation of optimal drying
and storage practices have mostly eliminated
harmful exposures in developed countries
(Brown et al. 1999; Phillips et al. 1994). The
application of these strategies in developing
countries is difﬁcult because of differences in
food production, such as the prominence of
subsistence farming in developing countries.
Furthermore, these countries often lack the
resources, technology, and infrastructure nec-
essary for routine food monitoring as well as
optimal drying and storage practices.
Consequently, > 5 billion people in devel-
oping countries worldwide are at risk of
chronic exposure to aﬂatoxins through conta-
minated foods (Shephard 2003; Williams
et al. 2004). Aﬂatoxin-associated health effects
pervade the developing world. These effects
could be mitigated or prevented through
effective and integrated use of current agricul-
tural knowledge and public health practice.
The discussion of this problem and its reme-
dies must include the underlying question of
food insufﬁciency and more general economic
challenges in developing countries. 
Outbreaks of acute aflatoxin poisoning
are a recurrent public health problem. In
2004, one of the largest, most severe aﬂatoxi-
cosis outbreaks occurred in Kenya, followed
by another outbreak in 2005 [Centers for
Disease Control and Prevention (CDC)
2004, unpublished data]. Both outbreaks
were caused by contamination of inade-
quately stored, homegrown maize. Given that
diseases in the developing world often go
unreported, the Kenya outbreaks probably
represent only a portion of the problem. The
full burden of disease attributable to chronic
aﬂatoxin exposure [e.g., hepatocellular carci-
noma (HCC), impaired growth, immune
suppression] remains undefined. These out-
breaks emphasize the need to quantify and
control aflatoxin exposure in developing
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Consecutive outbreaks of acute aﬂatoxicosis in Kenya in 2004 and 2005 caused > 150 deaths. In
response, the Centers for Disease Control and Prevention and the World Health Organization
convened a workgroup of international experts and health ofﬁcials in Geneva, Switzerland, in July
2005. After discussions concerning what is known about aﬂatoxins, the workgroup identiﬁed gaps
in current knowledge about acute and chronic human health effects of aﬂatoxins, surveillance and
food monitoring, analytic methods, and the efﬁcacy of intervention strategies. The workgroup also
identiﬁed public health strategies that could be integrated with current agricultural approaches to
resolve gaps in current knowledge and ultimately reduce morbidity and mortality associated with
the consumption of aﬂatoxin-contaminated food in the developing world. Four issues that warrant
immediate attention were identiﬁed: a) quantify the human health impacts and the burden of dis-
ease due to aflatoxin exposure; b) compile an inventory, evaluate the efficacy, and disseminate
results of ongoing intervention strategies; c) develop and augment the disease surveillance, food
monitoring, laboratory, and public health response capacity of affected regions; and d) develop a
response protocol that can be used in the event of an outbreak of acute aﬂatoxicosis. This report
expands on the workgroup’s discussions concerning aﬂatoxin in developing countries and summa-
rizes the ﬁndings. Key words: aﬂatoxins, biomonitoring, developing countries, food safety, hepati-
tis, hepatocellular carcinoma, public health, surveillance. Environ Health Perspect 114:1898–1903
(2006). doi:10.1289/ehp.9302 available via http://dx.doi.org/ [Online 24 August 2006]countries and highlight the potential role of
public health services.
In July 2005, the CDC and the World
Health Organization (WHO) convened a
workgroup of experts to identify culturally
appropriate, long-term public health strategies
to reduce aflatoxin exposure in developing
countries. The 40 members included interna-
tionally recognized scientists from diverse
backgrounds (public health, agriculture, ani-
mal health, trade, and social science). They
also included key public health officials and
stakeholders from countries heavily affected
by aﬂatoxins. The workgroup members iden-
tified gaps in current knowledge about the
acute and chronic human health effects of
aflatoxins. They also reviewed surveillance
and food monitoring schemes, analytic meth-
ods, and the efﬁcacy of intervention strategies.
Members discussed public health strategies
that could supplement agricultural efforts to
reduce or prevent exposure to aflatoxins in
the developing world. Last, the workgroup
discussed areas where efforts should be con-
centrated to reduce aflatoxin exposure and
subsequently ﬁll gaps in current knowledge.
Background
Aflatoxins are toxic secondary metabolites
produced by Aspergillus fungi. Aflatoxin B1
(AFB1), a known human carcinogen, is the
most potent and potentially lethal metabolite.
Agriculture scientists have been studying aﬂa-
toxins for > 40 years because of the wide-
spread occurrence of those contaminants and
their significant effect on crops (Eaton and
Groopman 1994; Fung and Clark 2004;
Shephard 2003; Wild and Turner 2002;
Williams et al. 2004). 
Aﬂatoxins can affect a wide range of com-
modities, including cereals, oilseeds, spices,
tree nuts, milk, meat, and dried fruit. Maize
and groundnuts are major sources of human
exposure because of their greater susceptibility
to contamination and frequent consumption
throughout the world. Aflatoxins are most
prevalent in latitudes between 40° N and
40° S of the equator, but the greatest health
risk lies within developing countries in tropical
regions, which rely on these commodities as
their staple food source. Food insufficiency
and lack of diversity substantially contribute
to the susceptibility of individuals and com-
munities to aﬂatoxins. 
Contamination is inﬂuenced by many fac-
tors and can occur at any stage of food pro-
duction, from preharvest to storage (Wilson
and Payne 1994). Factors that affect aﬂatoxin
contamination include the climate of the
region, the genotype of the crop planted, soil
type, minimum and maximum daily tempera-
tures, and daily net evaporation (Bankole and
Mabekoje 2004; Brown et al. 2001; Fandohan
et al. 2005a; Ono et al. 1999; Wilson and
Payne 1994). Aﬂatoxin contamination is also
promoted by stress or damage to the crop due
to drought before harvest, insect activity, poor
timing of harvest, heavy rains at and after har-
vest, and inadequate drying of the crop before
storage (Hawkins et al. 2005; Hell et al. 2000;
Ono et al. 2002; Turner et al. 2005). Levels of
humidity, temperature, and aeration during
drying and storage are also important factors.
Acute exposure to aﬂatoxins can result in
aﬂatoxicosis, which manifests as severe, acute
hepatotoxicity with a case fatality rate of
approximately 25% (Cullen and Newberne
1994). Early symptoms of hepatotoxicity from
aﬂatoxicosis can include anorexia, malaise, and
low-grade fever. Acute high-level exposure can
progress to potentially lethal hepatitis with
vomiting, abdominal pain, jaundice, fulminant
hepatic failure, and death. Outbreaks of acute
aﬂatoxicosis are a recurring public health prob-
lem in many developing countries including
Kenya and India. (CDC 2004; Krishnamachari
et al. 1975a, 1975b; Lye et al. 1995; Ngindu
et al. 1982).
HCC as a result of chronic aﬂatoxin expo-
sure has been well documented, generally in
association with hepatitis B virus (HBV) or
other risk factors (Chen et al. 2001; Henry
et al. 2002; Omer et al. 2004; Qian et al.
1994; Wang et al. 1996). The International
Agency for Research on Cancer (IARC) first
recognized aﬂatoxins as carcinogenic in 1976.
It subsequently reafﬁrmed naturally occurring
mixtures of aflatoxins and AFB1 as Group 1
carcinogens (carcinogenic to humans) (IARC
2002). Additional effects of chronic exposure
have not been widely studied, but are thought
to include immunologic suppression, impaired
growth, and nutritional interference (Cullen
and Newberne 1994; Fung and Clark 2004;
Patten 1981; Williams et al. 2004).
Aﬂatoxins in Developing
Countries
Baseline levels of exposure. Although a few
studies have provided estimates of daily expo-
sure to aﬂatoxins during non-outbreak periods
(Jiang et al. 2005; Park et al. 2004; Wang et al.
2001; Wild et al. 1992), more information is
needed concerning baseline levels of chronic
exposure for vulnerable populations. This
would allow for a better understanding and
quantiﬁcation of the health effects associated
with chronic exposure and for a better estimate
of the level of aﬂatoxin exposure necessary to
trigger an outbreak. Such knowledge would
also allow for the evaluation of the efﬁcacy of
public health and agricultural interventions.
Health impact and burden of disease
caused by chronic exposure. HCC is the sixth
most prevalent cancer worldwide. Developing
countries have a higher incidence rate, with
approximately 82% of the 600,000 new cases
each year occurring in developing countries
(Parkin et al. 2005). The age adjusted
incidence per 100,000 in middle Africa is
27.8 for men and 13.4 for women compared
with 6.2 and 1.7 in Western Europe and 5.3
and 1.9 in North America. Only China has a
higher incidence, at 37.9 and 14.2.
The burden of HCC attributable to aﬂa-
toxins when accounting for comorbidities,
such as HBV, is not known. Several studies in
China have indicated that combined exposure
to HBV and aflatoxins is associated with a
much higher risk of HCC (Qian et al. 1994;
Wang et al. 1996). This interaction has not
been studied in other high risk areas, such as
sub-Saharan Africa. The molecular mecha-
nism of the interaction between HBV and
aflatoxins also is not known (Turner et al.
2002; Wild and Turner 2002). Quantifying
the proportion of HCC attributable to afla-
toxin exposure, to HBV, and to the inter-
action of aflatoxin exposure and HBV will
help identify the best public health strategies
to reduce HCC, including the benefits and
limits of widespread HBV vaccination. 
Additional health effects associated with
chronic aﬂatoxin exposure have not been well
studied. Preliminary evidence suggests an
interaction between chronic aﬂatoxin exposure
and malnutrition, immunosuppression,
impaired growth, and consequently, suscepti-
bility to infectious diseases such as malaria and
HIV/AIDS. Experimental animal evidence
suggests that chronic exposure to aflatoxins
may lead to impaired immunity, reduced
uptake of nutrients from the diet, and growth
retardation (Hall and Wild 1994; Miller and
Wilson 1994). Several studies of children in
Benin and Togo using aflatoxin albumin
adducts as biomarkers have shown an associa-
tion between aﬂatoxin exposure and impaired
growth (Gong et al. 2002, 2003, 2004). In a
recent study in Ghana, higher levels of
AFB1–albumin adducts in plasma were associ-
ated with lower percentages of certain leuko-
cyte immunophenotypes (Jiang et al. 2005). A
study in Gambian children found an associa-
tion between serum aﬂatoxin–albumin levels
and reduced secretory immunoglobulin A lev-
els in saliva (Turner et al. 2003). Although
these studies show an association between aﬂa-
toxin levels and indicators of the immune sys-
tem, further investigations of the impact of
this association on health is needed. 
The health impact of aﬂatoxins is compli-
cated by exposure to multiple mycotoxins.
Foods affected by aﬂatoxins are also suscepti-
ble to other types of mycotoxins, and multiple
mycotoxins can coexist in the same commod-
ity (Bankole and Mabekoje 2004; Fung and
Clark 2004; Speijers and Speijers 2004).
Therefore, individuals may be exposed to vari-
ous combinations of mycotoxins (Council for
Agricultural Science and Technology 2003).
The health effects associated with exposure to
Aflatoxins in developing countries
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(Speijers and Speijers 2004). A better under-
standing of exposure to multiple mycotoxins
and the health effects associated with the inter-
actions between mycotoxins would clarify the
true health consequences of mycotoxins.
Efﬁcacy of interventions. The appropriate
adaptation of commercial practices from devel-
oped countries into interventions for develop-
ing countries and information regarding the
efﬁcacy of these interventions is essential and
currently missing. It is unclear whether these
are applicable in developing countries because
of limited resources, technology, and infra-
structure as well as inherent differences in food
production. For example, in Kenya, subsis-
tence farmers consume their own grain, but
they also sell part of their harvest to local mar-
kets. They may later themselves purchase grain
from these markets when their own supplies
are depleted (Lewis et al. 2005). 
Interventions to reduce exposure to aﬂatox-
ins can occur at various stages of food produc-
tion and preparation (Table 1). Interventions
vary in their cost, labor intensiveness, applica-
bility, and effectiveness in preventing aﬂatoxin
development. The appropriate intervention or
combination of interventions depends on the
crop and the country. Therefore, further evalu-
ation is needed with consideration towards the
sustainability, cultural acceptability, economic
feasibility, ethical implication, and overall
effectiveness of potential interventions.
Preharvest interventions. The presence
and growth of Aspergillus on preharvested
crops can be reduced through agricultural
practices such as proper irrigation and pest
management. Preharvest interventions include
choosing crops with resistance to drought, dis-
ease, and pests and choosing varieties that are
genetically more resistant to the growth of the
fungus and the production of aﬂatoxins (Chen
et al. 2001; Cleveland et al. 2003; Cotty and
Bhatnagar 1994). Elimination of inoculum
sources, such as infected debris from the previ-
ous harvest, may prevent infection of the crop
(Olanya et al. 1997). A biopesticide consisting
of a nonaﬂatoxigenic strain of Aspergillus may
competitively exclude toxic strains from
infecting the crop (Cleveland et al. 2003;
Dorner et al. 1999). However, the allergenic
and human health aspects of the atoxigenic
strain need to be evaluated. 
Postharvest drying and storage. Before
storage, properly drying crops can prevent the
development of aﬂatoxins. Sorting and dispos-
ing of visibly moldy or damaged kernels before
storage is an effective method for reducing but
not eliminating the development of aﬂatoxins
(Fandohan et al. 2005a; Turner et al. 2005).
Moisture, insect, and rodent control during
storage can prevent damage to the crop, which
would promote aflatoxin development.
Aﬂatoxin contamination of maize is inﬂuenced
by the structure used for storage, the length of
time in storage, and the form of maize stored
(i.e., with husk, without husk, or loose grain)
(Hell et al. 2000). A community-based inter-
vention trial in Guinea, West Africa, focused
on thorough drying and proper storage of
groundnuts in subsistence farm villages
(Turner et al. 2005). The trial achieved a
60% reduction in mean serum aflatoxin–
albumin levels in people in intervention vil-
lages. This study illustrates that simple and
inexpensive postharvest methods can have a
signiﬁcant impact. 
Postharvest food preparation. Inter-
ventions during food preparation or consump-
tion involve removing contaminated portions
of food, diluting contaminated food with
uncontaminated food, neutralizing aﬂatoxins
present in food, or altering the bioavailability
of the aﬂatoxins consumed. Simple food prepa-
ration methods such as sorting, washing,
crushing, and dehulling may reduce aﬂatoxin
levels (Fandohan et al. 2005b; Lopez-Garcia
and Park 1998; Park 2002). Aﬂatoxins are not
largely affected by routine cooking tempera-
tures, but traditional methods of cooking food
with alkaline compounds (i.e., nixtamalization)
have been used to reduce aﬂatoxin exposure.
Although the chemical reaction may temporar-
ily inactivate aﬂatoxins, the reaction may then
reverse in the gastric acid of the stomach (Elias-
Orozco et al. 2002; Fandohan et al. 2005b;
Mendez-Albores et al. 2004; Price and
Jorgensen 1985). 
Additional strategies for reducing aﬂatox-
ins, including enterosorption and chemopro-
tection, attempt to reduce the effects of
aﬂatoxin exposure or the bioavailable portion
of aﬂatoxins in food. Enterosorption is the use
of clay, such as NovaSil, a processed calcium
montmorillonite clay with a high afﬁnity for
aﬂatoxins (Phillips 1999; Phillips et al. 2002;
Wang et al. 2005). Clay has been used as an
anticaking additive in animal feed and has
been shown to protect animals from ingested
aflatoxins. Chemoprotection is the use of
chemical {e.g., oltipraz [4-methyl-5-(2-
pyrazinyl)-1,2-dithiole-3-thione], chloro-
phylin} or dietary intervention (e.g., eating
broccoli sprouts, drinking green tea) to alter
the susceptibility of humans to carcinogens
and has been considered as a strategy to reduce
the risk of HCC in populations with high
exposures to aflatoxins (Bolton et al. 1993;
Kensler et al. 1994, 2004; Wang et al. 1999).
These strategies, however, are expensive and
are therefore difficult to implement in poor
communities. The efﬁcacy, safety, and accept-
ability of enterosorption and chemoprotection
require further study.
Awareness campaigns. During the 2005
Kenya outbreak, individuals who received
information on maize drying and storage
through an awareness campaign run by the
Food and Agricultural Organization and
Kenya’s Ministry of Health and Ministry of
Agriculture had lower serum aflatoxin levels
than those who did not receive this informa-
tion (CDC, unpublished data). Awareness
campaigns should use systems that are in place
already for disseminating information to sub-
sistence farmers (James 2005). Awareness
campaigns should distribute information to
multiple organizations and use multiple means
for spreading information to reach a broad
range of people, given the diversity of cultures
and remoteness of villages. Organizations pro-
viding information need to identify groups
that are not receiving messages from current
campaigns and appropriate methods for reach-
ing those populations. They should also deter-
mine why individuals or groups are unwilling
or fail to adopt recommendations.
Analysis of food and biologic specimens.
Determining the relationship between afla-
toxin concentrations in food or biologic speci-
mens and potential health outcomes is central
to quantifying and mitigating the aflatoxin
burden in the developing world. To improve
public health, the goals of toxicologic labora-
tory testing include
• establishing a baseline in humans and the
environment (e.g., foods, communities,
individuals) 
• monitoring exposure 
•confirming exposure or diagnosis of
poisoning 
• excluding other causes of disease 
Strosnider et al.
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Table 1. Interventions for preventing or reducing aﬂatoxin exposure.
Stage in food production Interventions References
Preharvest Timing of planting; crop planted;  Brown et al. 2001; Chen et al. 2001; Cleveland 
genotype of seed planted; irrigation;  et al. 2003; Cotty and Bhatnagar 1994; Dorner 
insecticides; competitive exclusion;  et al. 1999; Munkvold 2003; Wilson and Payne 
timing of harvest 1994
Postharvest:  Hand sorting; drying on mats; sun  Fandohan et al. 2005a; Hawkins 
drying and storage drying; storing bags on wooden  et al. 2005; Hell et al. 2000; Munkvold 2003;
pallets or elevated off ground;  Ono et al. 2002; Turner et al. 2005
insecticides; rodent control
Postharvest:  Hand sorting; winnowing; washing;  Castells et al. 2005; Elias-Orozco et al. 2002; 
food preparation crushing and dehulling;  Fandohan et al. 2005b; Kensler et al. 2004; 
nixtamalization; acidiﬁcation;  Mendez-Albores et al. 2005; Mendez-Albores 
chemoprotectant; enterosorption et al. 2004; Munkvold 2003; Price and Jorgensen 
1985; Wang et al. 2005• monitoring the effectiveness of prevention
interventions 
• and guiding therapeutic interventions. 
Interpretation and application of aflatoxin
results to achieve these goals are limited and
vary with the type of laboratory method and
sample media. 
Aflatoxin food concentrations. Testing
food for aﬂatoxins is constrained by two limi-
tations. First, obtaining a representative sam-
ple of food from subsistence farmers is
difficult given the need for large samples,
multiple vulnerable crops on one farm, the
distance between farmers, villages, and labora-
tories, and uneven distribution of aflatoxin
contamination within a food supply. 
Second, little is known about the speciﬁc
threshold levels associated with adverse health
effects. Agricultural data have established a
relationship between concentrations of afla-
toxins in food and acute aflatoxicosis. This
has led to regulatory limits on aflatoxin in
feed of 100–300 ppb for mature animals and
20–100 ppb for immature and dairy animals
in the United States (Phillips et al. 1994).
Limits for foods for human consumption in
the industrialized world (including exports
from developing countries) are 4–20 ppb;
those limits are based on limited information
from risk assessments of HCC (Henry et al.
1999; van Egmond 2002). Information is
extremely limited concerning health effects
associated with aflatoxin concentrations
between 20 ppb and 300 ppb.
AFB1 adducts and urine immunoassay.
For epidemiologic studies, biomarkers in
serum and urine provide a better estimate of
aflatoxin exposure than does food analysis.
Aflatoxin metabolites in urine reflect recent
exposure (i.e., 2–3 days), whereas aflatoxin
albumin adducts in blood reﬂect exposure over
a longer period (i.e., 2–3 months) (Groopman
et al. 1994). These analyses, however, are labor
intensive and expensive (McCoy et al. 2005;
Sheabar et al. 1993; Wild et al. 1990). 
Information regarding the interpretation
and application of AFB1 adducts and urine
immunoassays is also limited (Groopman and
Kensler 2005; Turner et al. 1998; Wild and
Turner 2001). Aflatoxin metabolites or
adducts in urine and serum indicate exposure,
but do not necessarily equate to adverse health
effects. Some studies have examined the corre-
lation of aﬂatoxin intakes to biomarker levels
(Groopman et al. 1992; Wild et al. 1992) and
to disease (Azziz-Baumgartner et al. 2005;
Gong et al. 2004; Qian et al. 1994; Wang
et al. 1996). More research is needed to fur-
ther elucidate the correlation between afla-
toxin levels in biologic specimens and adverse
health effects. Research must also clarify the
relationship between aflatoxin levels in bio-
logic specimens and levels in food. 
Appropriate laboratory methods for devel-
oping countries. Current methods can detect
very low levels of aflatoxins and aflatoxin
metabolites in food and biologic media. The
use of these methods within developing coun-
tries is limited by practical considerations, such
as resources and infrastructure. Methods for
testing food and biologic specimens need to be
adapted to ﬁt the surveillance and epidemio-
logic needs of developing countries. A simple
screening method, adapted for developing
countries, would benefit subsistence farmers
and be useful to public health and agriculture
institutions. These institutions would also ben-
eﬁt from sustainable and reliable conﬁrmatory
methods for use in centralized laboratories. 
Field methods. Simple and inexpensive
ﬁeld screening methods, such as portable, lat-
eral ﬂow immunochromatographic assays, are
available to determine that food is sufﬁciently
free of aflatoxins. Field methods can be per-
formed with minimal training or equipment
and can be performed onsite (i.e., at a farm or
grain silo). Field methods for aﬂatoxin analysis
allow for rapid confirmation or exclusion of
possible exposure at a reasonable cost, thus
allowing ofﬁcials to quickly determine the need
for further evaluation and intervention. Such
methods would prove beneﬁcial in developing
countries where the remoteness of villages and
long distances to a centralized laboratory make
it impractical to take samples from villages,
analyze them in the laboratory, and then travel
back to the village to deliver the results.
Currently, however, these lack direct
applicability in developing countries. For
example, one ﬁeld screening method uses dip-
sticks that indicate whether a sample is above
or below the regulatory limit of 20 ppb. In
developing countries, especially during an out-
break, most samples would be > 20 ppb.
Therefore, an investigator would need to dif-
ferentiate between samples at levels > 20 ppb.
Such field tests could prove effective if they
were adjusted to action levels suitable for devel-
oping countries. Field methods for the analysis
of biologic samples have not been developed.
However, the same concept of using dipsticks
can be applied to ﬁeld tests for biologic speci-
mens. Efforts to limit aflatoxin exposure in
developing countries could be enhanced by
Aflatoxins in developing countries
Environmental Health Perspectives • VOLUME 114 | NUMBER 12 | December 2006 1901
Figure 1. Overview of preparedness, surveillance, and response activities for preventing acute aﬂatoxico-
sis in countries in development.
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Level 2 responsereducing the cost and improving the durability,
ease of transport, and usability of ﬁeld meth-
ods. Ideally, such methods should be easy to
use and should not require electricity.
Laboratory methods. Laboratory methods
can be used to confirm results of field tests.
They are more precise, but also more labor
intensive and costly. These methods require
instrumentation or techniques not suited to
working onsite. They require regular mainte-
nance of instrumentation, training of person-
nel, and a ready supply of reagents and
materials (Trucksess and Wood 1994). The
best laboratory method for testing either food
or biologic specimen is one that balances the
need for quick, accurate results with limitations
in resources and infrastructure. Current labora-
tory methods require further refinement to
improve their usability in developing countries.
Thin-layer chromatography is a well-suited
laboratory method for testing food samples,
given its reliability and simplicity (Shephard
and Sewram 2004; Stroka and Anklam 2000).
It is labor intensive, however, and limited in
the number of samples that can be tested in a
day. Alternatives for food analysis include com-
mercially available aﬂatoxin testing kits, which
are less labor intensive and faster, but also more
expensive (Scott and Trucksess 1997).
Early warning system for developing coun-
tries. To prevent future outbreaks, developing
countries could beneﬁt from an early warning
system designed to detect food contamination
that could cause illness (Figure 1) (Park 1995).
Public health surveillance is the ongoing sys-
tematic collection, analysis, interpretation, and
dissemination of data regarding a health-related
event. Those data are used in public health
actions to reduce morbidity and mortality and
to improve health (CDC 2001). To create an
effective and sustainable system, health surveil-
lance and food and biologic monitoring strate-
gies must be adapted to meet the needs of
developing countries. Early warning signs need
to be validated and response protocols need to
be developed.
Previous outbreaks in Kenya have been
identiﬁed by physicians who noticed an increase
in cases of jaundice, despite a lack of any orga-
nized or official reporting system (Azziz-
Baumgartner et al. 2005). Although a national
reporting system for jaundice would prove bene-
ﬁcial for developing countries, the baseline rate
of jaundice and all its possible causes are not
known. In addition, aﬂatoxicosis conﬁrmation
tests using biologic markers are limited.
However, an active and organized reporting sys-
tem of possible aﬂatoxin cases may allow for ear-
lier detection of potential outbreaks. 
An early warning system should also
involve monitoring aflatoxin levels in food
sources or individuals to prevent or reduce the
health affect. Monitoring aflatoxin levels in
food or individuals to identify those at risk for
disease is more difﬁcult than monitoring rates
of jaundice. However, food and biologic moni-
toring may identify susceptibility sooner and
allow for a more timely intervention. A robust
monitoring or surveillance system would be dif-
ficult to establish and sustain. To maximize
resources, a targeted monitoring or surveillance
system for high-risk areas or populations should
be used. The specimen (food, urine, or serum)
most appropriate for the country’s capacity
should be collected. A combination of rapid
ﬁeld test and laboratory conﬁrmation tests that
analyzes aﬂatoxins in food or biologic samples
would be ideal for an early warning system.
In addition to increase in jaundice cases
or the detection of aﬂatoxin in food and bio-
logic samples, other factors that indicate or
influence aflatoxin contamination could be
incorporated. Deaths of livestock or domestic
animals, which are often given lower-quality
grain, or modeling of aﬂatoxin contamination
to weather conditions from planting to
postharvest (de la Campa et al. 2005), could
also serve as indicators of aflatoxin. Both
would require further validation and an infra-
structure for monitoring and dissemination of
information. Ultimately, an early warning sys-
tem should rely on multiple sources of infor-
mation and triggers that would set in motion
various responses for preventing or reducing
an outbreak of aﬂatoxicosis.
An early warning system must include a
response protocol to prevent further aﬂatoxin
exposure and associated health outcomes once a
contaminated food source is identiﬁed. A pro-
tocol can be effective only if the infrastructure
and funds to replace contaminated food exist
and a method for identifying families in need
has been determined. For an early warning sys-
tem to succeed, key members from various gov-
ernment agencies, the health care sector, and
nongovernmental organizations need to be part
the development and implementation of effec-
tive communication and response strategies.
Conclusions
The aflatoxin workgroup brought together a
diverse group of experts to identify public
health strategies, which complement agricul-
tural strategies, to reduce aﬂatoxin exposure in
developing countries. Although a great deal is
known about aﬂatoxins, little is known about
aflatoxin exposure and the resulting health
effects in developing countries. Even without a
complete understanding of the public health
problem caused by aflatoxins, it is clear that
acute aﬂatoxicosis is preventable and chronic
exposure can be reduced. Efforts to reduce aﬂa-
toxin exposure require the commitment of suf-
ﬁcient resources and the collaboration between
the agriculture and public health communities
and between the local, regional, national, and
international governing bodies. Four issues that
warrant immediate attention include: 
• quantifying the human health impacts and the
burden of disease due to aﬂatoxin exposure 
• compiling an inventory, evaluating the efﬁ-
cacy, and disseminating results of ongoing
intervention strategies 
• developing and augmenting the disease sur-
veillance, food monitoring, laboratory, and
public health response capacity of affected
regions 
• and developing a response protocol that can
be used in the event of an outbreak of acute
aﬂatoxicosis. 
These steps will provide much needed
knowledge about the pattern and resulting
health effects of aflatoxin exposure and will
enable the development of effective, culturally
appropriate interventions for reducing
chronic levels of exposure. Although aﬂatoxin
exposure is not a new issue, it requires new
strategies to address it effectively within devel-
oping countries, where aflatoxin exposure is
intertwined with the issues of food insecurity
and insufﬁciency. The consecutive outbreaks
in Kenya emphasize the imperative for action.
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